Overall, our findings emphasize the significance of simultaneously targeting TP53-associated lncRNAs, specifically MEG3, and linc-ROR, to modulate cell proliferation and enhance cell survival in CRC. This evidence concerns the gene LINC-ROR and colorectal carcinoma.